Showing results (901-910 of 2,413) with videos related to
Sort By:
Pageof 242
Journal of Medical Economics|April 3, 2012
Healthcare resource use in advanced prostate cancer patients treated with docetaxelManeesha Mehra, Ying Wu, Ravinder DhawanJournal of Medical Economics|May 31, 2011
Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care populationMayur M Amonkar, Benjamin Chastek, Navendu Samant, et al.Journal of Medical Economics|May 14, 2011
Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UKAmélie Beaudet, James L Palmer, Louise Timlin, et al.Journal of Medical Economics|June 23, 2011
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costsAndrew P Yu, Rym Ben-Hamadi, Eric Q Wu, et al.Journal of Medical Economics|October 25, 2011
The association of pain with labor force participation, absenteeism, and presenteeism in SpainPaul C Langley, Jesús Tornero Molina, César Margarit Ferri, et al.Journal of Medical Economics|November 10, 2016
Healthcare costs of urinary tract infections and genital mycotic infections among patients with type 2 diabetes mellitus initiated on canagliflozin: a retrospective cohort studyTony B Amos, Leslie Montejano, Paul Juneau, et al.Journal of Medical Economics|December 25, 2016
Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritisBenjamin Chastek, Laura K Becker, Chieh-I Chen, et al.Journal of Medical Economics|December 31, 2016
Within the triangle of healthcare legacies: comparing the performance of South-Eastern European health systemsMihajlo Michael Jakovljevic, Jelena Arsenijevic, Milena Pavlova, et al.Journal of Medical Economics|March 29, 2014
Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapyGeorge J Wan, Chris M Kozma, Terra L Slaton, et al.Journal of Medical Economics|April 25, 2014
Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphomaGregory B Kruse, Michele H Potashman, Spyros Stavrakas, et al.Pageof 242